SMSPHARMABSESMS Pharmaceuticals Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 22 Aug, 2025 · 10:34 IST

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 21, 2025 for Hima Bindu Potluri

Pledge ReleasedOwnership Changes View source PDFExplain this filing

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.4%Reaction day
₹240.40
prior close
₹238.95
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-0.8% vs market
Pharmaceuticals peers, median of 151sector-0.1%-1.3% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.5
15m
-0.3
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.4-0.6-0.8-0.1-1.3
Next day
-2.6-0.7-1.9-0.5-2.1
2d
-3.9-2.4-1.4-1.6-2.3
3d
-7.4-3.1-4.3-2.7-4.8
4d
-1.6-3.3+1.7-2.9+1.3
5d
-0.6-2.0+1.5-1.6+1.0
1w
-2.3-0.2-2.1-0.9-1.4
15d
+21.1+0.7+20.3-0.4+21.4
1m
+17.7+1.3+16.4-0.0+17.7
2m
+17.0-0.2+17.1-2.8+19.8
3m
+12.7-3.6+16.4-6.2+18.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hima Bindu Potluri, a promoter of SMS Pharmaceuticals Ltd, filed a disclosure under SEBI SAST Regulations regarding changes in encumbrance of shares. On 19 August 2025, 30 lakh equity shares were released from a Non-Disposal Undertaking (NDU). On 20 August 2025, the same 30 lakh shares were pledged, with Annexure-II indicating this is connected to a debt instrument. The net effect is neutral in terms of share count — the encumbrance was simply restructured from an NDU into a pledge, with no change in the total number of encumbered shares held by the promoter.

Likely market impact

No change in the promoter's overall encumbered position, but the shift from NDU to pledge suggests a new loan or debt obligation backed by these shares. Shareholders should watch for any further disclosures on the purpose of the debt and whether more shares are pledged in the future.